Influence of FcγRIIa-Expressing Cells on the Assessment of Neutralizing and Enhancing Serum Antibodies Elicited by a Live-Attenuated Tetravalent Dengue Vaccine

Influence of FcγRIIa-Expressing Cells on the Assessment of Neutralizing and Enhancing Serum Antibodies Elicited by a Live-Attenuated Tetravalent Dengue Vaccine

In vitro neutralization assays utilizing FcγRIIa-expressing cells provide evidence that serotype-specific antibody enhancement may not be a primary factor in the serotype-specific efficacy differences exhibited in the CYD-TDV trials.

Bibliographic Details
Main Authors:	Byers, Anthony M., Broder, Ryan, Haupfear, Kelly, Timiryasova, Tatyana M., Hu, Branda T., Boaz, Mark, Warren, William L., Jackson, Nicholas, Moser, Janice M., Guy, Bruno
Format:	Online
Language:	English
Published:	Oxford University Press 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689971/

Similar Items

The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1
by: Jessica C. Anania, et al.
Published: (2018-08-01)

Optimization and Validation of a Plaque Reduction Neutralization Test for the Detection of Neutralizing Antibodies to Four Serotypes of Dengue Virus Used in Support of Dengue Vaccine Development
by: Timiryasova, Tatyana M., et al.
Published: (2013)

Engineered antibody Fc variant with selectively enhanced FcγRIIb binding over both FcγRIIaR131 and FcγRIIaH131
by: Mimoto, F., et al.
Published: (2013)

An Fc?RIIa-binding peptide that mimics the interaction between Fc?RIIa and IgG
by: Cendron, A., et al.
Published: (2008)

Induction of Neutralizing Antibodies against Four Serotypes of Dengue Viruses by MixBiEDIII, a Tetravalent Dengue Vaccine
by: Zhao, Hui, et al.
Published: (2014)

A Rapid Immunization Strategy with a Live-Attenuated Tetravalent Dengue Vaccine Elicits Protective Neutralizing Antibody Responses in Non-Human Primates
by: Ambuel, Yuping, et al.
Published: (2014)

Erratum: A Rapid Immunization Strategy with a Live-Attenuated Tetravalent Dengue Vaccine Elicits Protective Neutralizing Antibody Responses in Non-Human Primates
Published: (2014)

Neutralizing Antibodies Inhibit HIV-1 Infection of Plasmacytoid Dendritic Cells by an FcγRIIa Independent Mechanism and Do Not Diminish Cytokines Production
by: Lederle, Alexandre, et al.
Published: (2014)

The impact of FcγRIIa and FcγRIIIa gene polymorphisms on responses to RCHOP chemotherapy in diffuse large B-cell lymphoma patients
by: ROŽMAN, SAMO, et al.
Published: (2016)

Polymorphisms of TNF-enhancer and gene for FcγRIIa correlate with the severity of falciparum malaria in the ethnically diverse Indian population
by: Sinha, Swapnil, et al.
Published: (2008)

Development of a Cell-Based Assay Measuring the Activation of FcγRIIa for the Characterization of Therapeutic Monoclonal Antibodies
by: Tada, Minoru, et al.
Published: (2014)

Human platelet activation by Escherichia coli: roles for FcγRIIA and integrin αIIbβ3
by: Watson, Callum N., et al.
Published: (2016)

Induction of Neutralizing Antibody Response against Four Dengue Viruses in Mice by Intramuscular Electroporation of Tetravalent DNA Vaccines
by: Prompetchara, Eakachai, et al.
Published: (2014)

Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: De-ITAM-izing Fc?RIIa
by: Gardiner, E., et al.
Published: (2008)

Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of Fc?RIIa and induce GPVI ectodomain shedding
by: Al-Tamimi, M., et al.
Published: (2009)

A tetravalent dengue nanoparticle stimulates antibody production in mice
by: Silva, Elisângela F, et al.
Published: (2012)

Genetic and Phenotypic Characterization of Manufacturing Seeds for a Tetravalent Dengue Vaccine (DENVax)
by: Huang, Claire Y.-H., et al.
Published: (2013)

Dengue Virus Neutralization in Cells Expressing Fc Gamma Receptors
by: Chawla, Tanu, et al.
Published: (2013)

Structural basis for Fc?RIIa recognition of human IgG and formation of inflammatory signaling complexes
by: Ramsland, Paul, et al.
Published: (2011)

Inhibition of destructive autoimmune arthritis in Fc?RIIa transgenic mice by small chemical entities
by: Pietersz, G., et al.
Published: (2009)

Simulations to compare efficacies of tetravalent dengue vaccines and mosquito vector control
by: THAVARA, U., et al.
Published: (2014)

Challenges to the Design of Clinical Trials for Live-Attenuated Tetravalent Dengue Vaccines
by: Russell, Philip K., et al.
Published: (2016)

Radiotracer injector: an industrial application (RIIA)
by: Tuan Norhafizah binti Tuan Zakaria
Published: (2011)

Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines
by: Boero, Silvia, et al.
Published: (2015)

Erratum to: Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines
by: Boero, Silvia, et al.
Published: (2016)

Increased platelet expression of FcGammaRIIa and its potential impact on platelet reactivity in patients with end stage renal disease
by: Serrano, Feliciano A, et al.
Published: (2007)

The Immunodominance Change and Protection of CD4+ T-Cell Responses Elicited by an Envelope Protein Domain III-Based Tetravalent Dengue Vaccine in Mice
by: Chen, Hsin-Wei, et al.
Published: (2015)

Dengue Virus Infection-Enhancing Activity in Serum Samples with Neutralizing Activity as Determined by Using FcγR-Expressing Cells
by: Moi, Meng Ling, et al.
Published: (2012)

Anti-malarial IgG subclasses pattern and FcγRIIa (CD32) polymorphism among pregnancy-associated malaria in semi-immune Saudi women
by: Nasr, Amre, et al.
Published: (2013)

Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2–16 Years in Asia and Latin America
by: Olivera-Botello, Gustavo, et al.
Published: (2016)

The role of Fc–FcγR interactions in IgG-mediated microbial neutralization
by: Bournazos, Stylianos, et al.
Published: (2015)

Analysis of HLA DR, HLA DQ, C4A, FcγRIIa, FcγRIIIa, MBL, and IL-1Ra allelic variants in Caucasian systemic lupus erythematosus patients suggests an effect of the combined FcγRIIa R/R and IL-1Ra 2/2 genotypes on disease susceptibility
by: Jönsen, Andreas, et al.
Published: (2004)

Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia
by: Dorigatti, Ilaria, et al.
Published: (2015)

Therapeutic Efficacy of Antibodies Lacking FcγR against Lethal Dengue Virus Infection Is Due to Neutralizing Potency and Blocking of Enhancing Antibodies
by: Williams, Katherine L., et al.
Published: (2013)

Immunogenicity and Safety of a Recombinant Tetravalent Dengue Vaccine in Children and Adolescents Ages 9–16 Years in Brazil
by: Dayan, Gustavo H., et al.
Published: (2013)

Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice
by: Chiang, Chen-Yi, et al.
Published: (2016)

Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties
by: Liu, Yan, et al.
Published: (2014)

Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates
by: Strouts, Fiona R., et al.
Published: (2016)

Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials
by: Gailhardou, Sophia, et al.
Published: (2016)

Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone
Published: (1996)